#United States #Irvine, California #InMode Ltd #Medical Technologies #Michael Dennison

InMode Appoints Michael Dennison as President of North America

InMode Ltd., a premier global provider of innovative medical technologies, has officially appointed Michael Dennison, who previously served as Vice President of Sales, to the role of President for North America. This executive transition, announced on November 3, 2025, is poised to enhance the company’s strategic direction in the region.

Michael Dennison brings nearly a decade of leadership experience at InMode, having progressed through various sales roles and demonstrating exceptional performance in each position. His journey began as a District Sales Manager and saw him scale to the Vice President of Sales, during which time he successfully drove national revenue growth, increased market share, and fortified the distribution network throughout North America.

Moshe Mizrahy, CEO of InMode, expressed his enthusiasm about Dennison’s appointment: "This promotion marks an exciting new chapter for InMode, led by a visionary leader with a proven commitment to cultivating talent and driving market excellence. Dennison's extensive industry experience and inspirational leadership will be pivotal in advancing our strategic initiatives and accelerating growth, as part of our North American restructuring."

In his own words, Dennison stated, "I am honored to continue building on InMode's strong foundation. Together, we will accelerate momentum in the North American market, deliver greater value to our partners, and set new standards of excellence across the aesthetic and medical device industry."

Before joining InMode, Dennison had a fruitful career at Cynosure, where he was renowned for consistently surpassing sales targets and for building high-performing teams that contributed significantly to revenue growth. His extensive background in the aesthetic medical device industry equipped him with the necessary skills and insights to lead InMode in its North American endeavors effectively.

As InMode continues to evolve and expand its influence in the medical technology sector, Dennison's leadership is expected to guide the company through its restructuring phase, enhancing its strategic initiatives and fostering a culture of innovation. InMode is widely recognized for developing, manufacturing, and marketing devices that leverage cutting-edge radiofrequency (RF) technology, aiming to revolutionize both emerging surgical procedures and existing treatment methodologies. The company offers a comprehensive range of products across diverse medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.

In conclusion, with Michael Dennison at the helm as President of North America, InMode is well-positioned for future growth, and the industry is keenly awaiting how his leadership will shape the company’s trajectory and its impact on the medical technology landscape. For more information about InMode and its innovative technologies, interested parties are encouraged to visit www.inmodemd.com.